Ready to submit? Start a new submission or continue a submission in progress

Go to submission site (link opens in a new window)

Journal overview

Please note that Autoimmunity converted to a full Open Access journal from Volume 56 (2023). Previous volumes will continue to provide access through a Pay to Read model.

Autoimmunity is an international peer-reviewed journal that publishes articles on cell and molecular immunology, immunogenetics, molecular biology as relevant to immunity and autoimmunity. Current understanding of immune and autoimmune responses is being furthered by the progress in cell biology and molecular methods that has recently been little short of spectacular. Autoimmunity is interested in immune system cells, such as innate lymphoid cells, T cells and B cells, as well as molecular mediators of the immune system. Particular attention is given to regulatory mechanisms of T cells and (B cell) antibody responses, with emphasis on immune cell intrinsic epigenetic and metabolic processes. The scope of Autoimmunity extends to the cellular and molecular mechanisms that underpin systemic and organ-specific autoimmune responses as well as immune and autoimmune disorders. The journal reflects the immunology areas in which scientific progress is most rapid. It is a valuable tool to basic and translational researchers in cell biology, genetics and molecular biology of immunity and autoimmunity.

Autoimmunity accepts Research Articles, Review Articles, Brief Reports and Editorials for publication. 

Read the Instructions for Authors for information on how to submit your article.

Please note, from 2023 the Print ISSN is not in active use as this journal is no longer published in print.

Read full aims and scope

Latest issues

Advertise in this journal

Reach an engaged target audience and position your brand alongside authoritative peer-reviewed research by advertising in Autoimmunity.

Explore advertising options